The Global Long-acting Injectable Medications Market size is projected to reach USD million by 2027, from USD million in 2020, at a CAGR of 5% during 2021-2027.
Long-acting injectables (LAIs) are a unique tool used by psychiatric pharmacies to help improve patient outcomes. They offer many advantages over oral therapy, including confirmed patient compliance, consistent drug delivery, predictable bioavailability, and prevention of antipsychotic drug overdose. It originates from indications such as schizophrenia and contraception, treatment and prevention of HIV.
(Get 15% Discount on Buying this Report)
A full report of Global Long-acting Injectable Medications Market is available at: https://www.orionmarketreports.com/request-sample/?id=69137
Market Segments
On the basis of product
- First-generation
- Second-generation
On the basis of the end users
- Schizophrenia
- Contraception
- HIV
- Others
Key Players
- Mapi Pharma
- Pharmathen
- Kashiv BioSciences
- DURECT
- Zogenix
- GSK
- Nanomi
- MedinCell
- Alkermes
- Oakwood Labs
Scope of the Report
The research study analyzes the global Long-acting Injectable Medications industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
A full report of Global Long-acting Injectable Medications Market is available at: https://www.orionmarketreports.com/long-acting-injectable-medications-market/69137/
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Long-acting Injectable Medications Market Report
1. What was the Long-acting Injectable Medications Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Long-acting Injectable Medications Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Long-acting Injectable Medications Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Long-acting Injectable Medications market.
- The market share of the global Long-acting Injectable Medications market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Long-acting Injectable Medications market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Long-acting Injectable Medications market.
For more customized data, request for report customization @ https://www.orionmarketreports.com/inquiry-before-buying/?id=69137
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
